Ofer Ben‐Izhak
- Oncology top 2%
- Cancer-related Molecular Pathways 12
- Cell Biology top 2%
- Proteoglycans and glycosaminoglycans research 12
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 8
- Otorhinolaryngology top 5%
-
- Salivary Gland Tumors Diagnosis and Treatment 12
-
- Fibroblast Growth Factor Research 12
- Glycosylation and Glycoproteins Research 11
- Ubiquitin and proteasome pathways 8
-
- Oral and Maxillofacial Pathology 11
- Co-authors
- Dan HershkoEdmond SaboIsraël VlodavskyNeta IlanMaanit ShapiraChaim LichtigBoris FutermanSharon Akrish
- Cited by
- OncologyCell BiologyCancer Research
- Journals
- Cancer (7 papers)Histopathology (5 papers)Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (3 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Ofer Ben‐Izhak
100 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 100
- Oncology 1.3k
- Cell Biology 486
- Cancer Research 358
- Pathology and Forensic Medicine 377
- Otorhinolaryngology 90
Countries citing papers authored by Ofer Ben‐Izhak
This map shows the geographic impact of Ofer Ben‐Izhak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofer Ben‐Izhak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofer Ben‐Izhak more than expected).
Fields of papers citing papers by Ofer Ben‐Izhak
This network shows the impact of papers produced by Ofer Ben‐Izhak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofer Ben‐Izhak. The network helps show where Ofer Ben‐Izhak may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ofer Ben‐Izhak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 6 | |
| 2 | 2019 | 23 | |
| 3 | 2016 | 19 | |
| 4 | 2014 | 34 | |
| 5 | 2012 | 10 | |
| 6 | 2011 | 70 | |
| 7 | 2010 | 26 | |
| 8 | TUNEL as a tumor marker of tongue cancer. | 2009 | 10 |
| 9 | 2009 | 17 | |
| 10 | 2009 | 1 | |
| 11 | 2008 | 10 | |
| 12 | 2008 | 43 | |
| 13 | 2006 | 76 | |
| 14 | 2006 | 33 | |
| 15 | 2005 | 10 | |
| 16 | 2005 | 13 | |
| 17 | 2002 | 8 | |
| 18 | Radiotherapy for plasmocytoma of the larynx. | 1999 | 1 |
| 19 | 1998 | 8 | |
| 20 | 1996 | 18 |
About Ofer Ben‐Izhak
Ofer Ben‐Izhak is a scholar working on Oncology, Oral Surgery, Cell Biology, Pathology and Forensic Medicine and Nephrology, having authored 100 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (12 papers), Salivary Gland Tumors Diagnosis and Treatment (12 papers), Fibroblast Growth Factor Research (12 papers), Proteoglycans and glycosaminoglycans research (12 papers), Glycosylation and Glycoproteins Research (11 papers), Oral and Maxillofacial Pathology (11 papers), Ubiquitin and proteasome pathways (8 papers) and Cancer Genomics and Diagnostics (8 papers). The work is most often cited by research in Oncology (1.3k citations), Cell Biology (486 citations), Cancer Research (358 citations), Pathology and Forensic Medicine (377 citations) and Otorhinolaryngology (90 citations). Ofer Ben‐Izhak has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Dan Hershko, Edmond Sabo, Israël Vlodavsky, Neta Ilan, Maanit Shapira, Chaim Lichtig, Boris Futerman, Sharon Akrish, Rafael M. Nagler and Gabriel M. Groisman. Their work appears in journals such as Cancer, Histopathology, Oral Surgery Oral Medicine Oral Pathology and Oral Radiology, Modern Pathology and The American Journal of Surgical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.